WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Cleveland Clinic Top 10 Medical Innovations for 2010

Details
Research
14 October 2009
The purpose of Cleveland Clinic's annual "Top 10 Medical Innovations" is to share the perspective on what innovations would help to re-shape health care in the next year. Top 10 are representing the final results of a rigorous selection process when clinicians and researchers at the Cleveland Clinic have been asked: "What game-changing medical technology, device, or therapy do you see breaking through in 2010?"
Read more ...

Health 2.0 on the Rise - 35% of U.S. Adults Use Social Media for Medical Information

Details
Research
09 October 2009
Manhattan ResearchAbout 35% of the U.S. adult population uses social media for health and medical purposes in 2009, according to pharmaceutical and healthcare market research company Manhattan Research's Cybercitizen Health™ v9.0. These 80 million Health 2.0 Consumers create or consumer content on health blogs, message boards, chat rooms, health social networks and health communities, and patient testimonials.
Read more ...

Physician Smartphone Adoption Rate to Reach 81% in 2012

Details
Research
06 October 2009
Manhattan ResearchPhysician smartphone adoption rates will experience significant growth over the next few years. Currently, 64% of U.S. physicians own smartphones, but this will increase to 81% penetration in 2012, according to the latest physician report from pharmaceutical and healthcare company Manhattan Research. "Physicians in 2012: The Outlook for On Demand, Mobile, and Social Digital Media", is part of the company's Taking the Pulse® market research and strategic advisory service.
Read more ...

102.3 Million Patients Online for Prescription Drug Information, Doubled in Past Four Years

Details
Research
02 October 2009
Manhattan ResearchSince 2005, the number of patients using the Internet to research prescription drug information has doubled to 102.3 million. Similarly, the overall number of eHealth Consumers, those online for any health and medical information, has also grown significantly over the past four years. This market now stands at 157.5 million consumers, or 1.6 times the number of eHealth Consumers in 2005.
Read more ...

EU-funded researchers hunt down tumour killers using bacteria

Details
Research
29 September 2009
Infamous bacteria impacting our lives are Salmonellae, usually found in chicken and eggs. But are they getting too much of a bad rap? EU-funded researchers in Germany may have actually succeeded in putting a positive spin on Salmonellae following the discovery that the bacteria can migrate into solid tumours and destroy them.
Read more ...

New Capgemini study points to recovery in the life sciences industry

Details
Research
29 September 2009
A new report released by Capgemini, one of the world's foremost providers of consulting, technology and outsourcing services, highlights the significant challenges faced by the life sciences industry in the current global market. Capgemini's Vision and Reality Report 2009 provides an in-depth look at the current global market for the life sciences industries including pharmaceutical, medical device, biotech and agribusiness.
Read more ...

How Oncologists Use the Internet and Other Technologies

Details
Research
18 September 2009
Manhattan ResearchOncologists are more likely than the overall population of U.S. physicians to visit pharmaceutical, biotech, and device corporate and product websites on a regular basis, according to pharmaceutical and healthcare market research company Manhattan Research. In fact, almost seventy percent of oncologists visit product websites monthly or more often.
Read more ...

More Pharma News ...

  1. EU-funded study finds pandemic swine flu infects cells deep inside lungs
  2. Essential ePharma Trends and Strategies for Marketing to Physicians and Patients in 2010
  3. Study reveals gene behind insulin resistance
  4. Uncovering the roots of the placebo effect
  5. VTT starts to investigate Bayer Schering Pharma's preclinical anti-cancer compounds
  6. Study: 3 out of 4 U.S. Nurses Recommend Health Websites to Patients
  7. Nanog protein essential for 'reprogramming' adult cells into stem cells
  • Start
  • Prev
  • 283
  • 284
  • 285
  • 286
  • 287
  • 288
  • 289
  • 290
  • 291
  • 292
  • Next
  • End

Business & Industry

  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
  • AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
  • Pfizer invests $43 billion to battle cancer

Research & Development

  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer
  • Engineered bacteria find tumors, then alert the authorities
  • First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research
  4. Vitamin A may help improve pancreatic cancer chemotherapy

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.